Ekonomi Haberleri

İçinde ('Altın ','USD ','Dolar ','EURO ','AVRO ','Faiz ','Gold ','Lira ','TRY ','USD ','Dollar ','cripto','crypto','Baş ','Chief ','Finance ','Finans ','Gayrimenkul','Kripto ','Küresel ') ve ('FED ','Stock ','NYSE ','S-400 ','F-35 ','Fitch ','S&P ','Moody's','Borsa ','IMKB ','Petrol ','Oil ','Merkez ','para ','money ','companies','company','Economist ','Ekonomist ','currencies','currency','Economy','Ekonomi','Economies','yatırım','Piyasa') ve ('ABD ',' US ',' EU ','Turkey','Turkish','Russia','China','Türkiye') kelime gruplarından en az 2 sinin içindeki kelimelerden birinin aynı anda geçtiği haberler.

Ekleyen: İnternet Robotu
Haber: Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: FDA declines to approve two more drugs tested in China; Pfizer Covid pill fails to prevent infection in household members
The FDA declined to approve two China-tested cancer treatments on Monday, raising concerns over the future of drugs tested in single-country trials.
https://www.statnews.com/pharmalot/2022/05/02/pfizer-covid19-fda-china-clinical-trials-biogen/?utm_campaign=rss
Etiketler: